Literature DB >> 14609212

The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.

Elisa Boden1, Qizhi Tang, Helene Bour-Jordan, Jeffrey A Bluestone.   

Abstract

CD4+CD25+ T cells regulate a variety of autoimmune and alloimmune responses including the development of autoimmune diabetes in non-obese diabetic (NOD) mice. We have examined the role of CD28/CTLA4/B7 interactions in the expansion and survival of CD4+CD25+ regulatory T cells (T(reg)) in this setting. CD28/ B7 interactions are essential in the development of T(reg) in the thymus and for their survival in the periphery. The CD28-mediated homeostasis of these cells is independent of Il2, OX40, CD40L, and survival factor Bcl-XI. In addition, analysis of T(reg) from CTLA4-deficient mice suggests that CTLA4 expression is not required for their development or function. However, non-activating anti-CTLA4 antibodies blocked the suppressor activity of regulatory cells in vitro. Thus, clinical application of co-stimulatory blockade using agents such as CTLA4Ig in the treatment of autoimmune disease may result in complicated outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609212     DOI: 10.1002/0470871628.ch5

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  17 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

3.  Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

Authors:  Damien Bresson; Lisa Togher; Evelyn Rodrigo; Yali Chen; Jeffrey A Bluestone; Kevan C Herold; Matthias von Herrath
Journal:  J Clin Invest       Date:  2006-04-20       Impact factor: 14.808

Review 4.  T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival.

Authors:  Mohammad A Khan; Sana Moeez; Suhail Akhtar
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

Review 5.  Regulatory T cells: immune suppression and beyond.

Authors:  Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

6.  Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.

Authors:  Gabriela Maria Wiedemann; Max Martin Ludwig Knott; Viola Katharina Vetter; Moritz Rapp; Sascha Haubner; Julia Fesseler; Benjamin Kühnemuth; Patrick Layritz; Raffael Thaler; Stephan Kruger; Steffen Ormanns; Doris Mayr; Stefan Endres; David Anz
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

7.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

8.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

Review 9.  Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

Authors:  O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

10.  TGF-beta and regulatory T cell in immunity and autoimmunity.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Clin Immunol       Date:  2008-09-16       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.